KINEX LABS products are sold exclusively for in-vitro research and laboratory use. By entering, you confirm you are 18 or older and a qualified researcher, and you will not use these compounds for human consumption.
Cagrilintide 10 mg is a long-acting amylin analogue under investigation in metabolic and satiety research. Amylin pathway research is a key area of study alongside incretin-based peptides.
Research Profile
Long-acting amylin analogue
Studied in satiety, gastric-emptying, and metabolic research models
Often researched in combination with GLP-1 pathway compounds
QC verified by HPLC and mass spectrometry
Specifications
Compound: Cagrilintide
Dosage: 10 mg per vial
Purity: ≥ 98% (HPLC)
Form: Lyophilized powder
Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
Specifications
Compound
Cagrilintide
Class
Amylin analogue (long-acting)
Dosage
10 mg per vial
Purity
≥ 98% (HPLC)
Form
Lyophilized powder
Appearance
White to off-white cake
Storage
Store lyophilized at 2–8 °C. Reconstituted: –20 °C, use within 30 days.
Reconstitution
Bacteriostatic water (sold separately)
Research Use
Investigational compound for laboratory research only.
